comparemela.com

Latest Breaking News On - Christopher thanos - Page 1 : comparemela.com

Actym Raises $59.5M In Series A funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Berkeley
California
United-states
Christopher-thanos
Boehringer-ingelheim-venture-fund
Actym-therapeutics
Illumina-ventures
Panacea-ventures

Actym Therapeutics Announces Significant Expansion of Senior Leadership

/PRNewswire/ Actym Therapeutics, a privately held biotechnology company developing STACT, a novel therapeutic platform that delivers immunomodulatory.

Stanford-university
California
United-states
Essex
Berkeley
South-korea
Korea
Julie-cherrington
Santa-barbara
Omkar-joshi
James-stutz
Christopher-thanos

Actym Therapeutics Announces Significant Expansion of Senior Leadership

Actym Therapeutics Announces Significant Expansion of Senior Leadership
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Stanford-university
California
United-states
Essex
Berkeley
South-korea
Korea
Julie-cherrington
Santa-barbara
Omkar-joshi
James-stutz
Christopher-thanos

Actym Therapeutics Announces Significant Expansion of Senior Leadership

/PRNewswire/ Actym Therapeutics, a privately held biotechnology company developing STACT, a novel therapeutic platform that delivers immunomodulatory.

Stanford-university
California
United-states
Essex
Berkeley
South-korea
Korea
Julie-cherrington
Santa-barbara
Omkar-joshi
James-stutz
Christopher-thanos

Actym Therapeutics Announces Significant Expansion of Senior Leadership

BERKELEY, Calif., May 12, 2022 /PRNewswire/ Actym Therapeutics, a privately held biotechnology company developing STACT, a novel therapeutic pl.

Stanford-university
California
United-states
Essex
Berkeley
South-korea
Korea
Julie-cherrington
Santa-barbara
Omkar-joshi
James-stutz
Christopher-thanos

vimarsana © 2020. All Rights Reserved.